Company Name : Brussels Laboratories Pvt Ltd
Address : 33, Changodar Industrial Estate, Sarkhej-Bavla Highway, Changodar-382210, Ahmedabad, Gujarat (India)
Tel No: 91-9574003451, 91-99044 00451
Email : info@brusselslaboratories.com
Website : http://brusselslaboratories.com/
Company Profile
Brussels Laboratories Pvt. Ltd. was established in the year 1993 in the Small Scale Sector, with the mission of providing Safe and Genuine Health Care products for the mankind & to cater to the growing demand of the market for quality medicines.
Land: 2700.00 Sq. yards. (with storage space)
Total Built-up Area: 3200.00 Sq. yards.
Up gradation of Plant at the cost of INR 20 Million in 2005 & 2006.
Our Drug Manufacturing License No. is G/1369 (Form No. 25) & G/1010 (Form No.28) issued by Food & Drugs Control Administration, Gandhinagar, Gujarat state, to manufacture Tablets (General & Beta Lactam), Capsules (General & Beta Lactam), Oral liquids, Beta Lactam Dry Syrups.
We produce a wide range of products, say more than 125 products under our own brand name & market it in the domestic market throughout India. Also we produce a wide variety of other formulations, with others Brand name under Contract Manufacturing / Loan License agreements with various Pharmaceutical Companies, as per their demand.Group turnover for the year 2009 – 10 was 90 Crores.
The Company is promoted by highly experienced and technically qualified personnel in pharmaceutical manufacturing and pharma business, supported by a strong team of qualified technical personnel, having very good experience in pharmaceutical formulation manufacturing.
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…